Timothy Angelotti is an associate professor within the Department of Anesthesiology, Perioperative and Pain Medicine at the Stanford University School of Medicine. In his clinical work, he specializes in the care of high risk, critically ill adult patients—during air medical transports, in the intensive care unit (ICU), or in the operating room. Angelotti received his BS in Chemistry from the University of Notre Dame, and subsequently received his MD and PhD (Pharmacology) degrees from the University of Michigan, where he was a fellow in the NIH-funded Medical Scientist Training Program. He continued his clinical training in Anesthesiology at Duke University and subsequently Intensive Care Medicine at Stanford University. Angelotti’s research has been in the area of molecular pharmacology, specifically on the study of ion channels, receptor proteins, and the sympathetic nervous system. He directed an NIH-funded basic science laboratory for over 12 years before switching his research focus toward translational medicine, specifically clinical pharmacology of vasopressor drugs in the ICU. Besides the NIH, he has received research funding from Stanford University, the American Heart Association (AHA), the Foundation for Anesthesia Education and Research (FAER), and corporate sponsors. He has published six book chapters, over thirty-two peer-reviewed research articles, and a dozen invited reviews and lectures frequently to pre-clinical medical students. In addition to American Friends of AvH, Angelotti also sits on the Scientific Review Board for the Spastic Paraplegia Foundation (SPF) and has served as an associate editor for Analgesia & Anesthesia. In addition, he holds several leadership positions with his department and Stanford University Hospital. Angelotti was an Alexander von Humboldt Foundation postdoctoral fellow based at the Technical University Munich (TUM) from 1995 to 1996 and in 2013, he returned to TUM on sabbatical as a recipient of an Alexander von Humboldt Foundation Return Fellowship.
